Lachman FOCUS Series:
How Quality Culture Affects Regulatory Outcomes

In today’s regulatory landscape, quality culture isn’t just a buzzword—it’s a decisive factor in inspection outcomes. Join us for an unfiltered conversation with former FDA professionals who’ve seen firsthand how organizational culture shapes compliance, risk management, and regulatory success.

This webinar explores the tangible ways quality culture influences engagement with the regulator across the product lifecycle: from development and readiness, to signal detection and control, inspection preparation, and post-market response and resilience. Through real-world accounts and practical insights, our expert panel will demystify what regulators look for beyond SOPs and metrics—and how companies can foster a culture that supports sustainable compliance.

Prepare to unlock untapped efficiencies within your processes, as The VIP Assist helps you transform hindsight into foresight, turning process pitfalls into pathways for success in a future-ready medical device industry.

Key takeaways include:

• A deeper understanding of how quality culture influences inspection outcomes, regulatory relationships, and long-term compliance
• Actionable strategies for cultivating leadership buy-in, transparency, and continuous improvement across your organization
• Real-world insights into how FDA investigators assess culture—and how to avoid the pitfalls that lead to 483s and warning letters

Whether you're a quality leader, regulatory affairs professional, or executive shaping strategy, this webinar will provide practical tools to elevate your organization’s quality mindset.

Watch on-demand now →

---